Written questions by Bennett.

How many qualified ophthalmic (a) consultants and (b) doctors there are who are able to treat glaucoma; how many people have glaucoma; and what estimate he has made of trends in these numbers over the next 10 years.

The UK National Screening Committee does not recommend screening for glaucoma because it is not clear if the tests which are available are accurate enough to be used in a screening programme. Regular sight tests are important in detecting glaucoma, which is why we recommend everyone having a sight test at least every two years. Free National Health Service sight tests are available for many, including children, those aged 60 years old and over, individuals on income-related benefits, and those diagnosed with, or considered at risk of, glaucoma.The Department does not hold information on the absolute numbers of people living with glaucoma at any one time in England, and therefore no estimate has been made on the numbers of people who will have glaucoma in the next 10 years. Data is also not held centrally on the number of qualified ophthalmic consultants and doctors who are able to treat glaucoma in the NHS.

What estimate his Department has made of the number of people who will have glaucoma in England in each of the next 10 years.

The UK National Screening Committee does not recommend screening for glaucoma because it is not clear if the tests which are available are accurate enough to be used in a screening programme. Regular sight tests are important in detecting glaucoma, which is why we recommend everyone having a sight test at least every two years. Free National Health Service sight tests are available for many, including children, those aged 60 years old and over, individuals on income-related benefits, and those diagnosed with, or considered at risk of, glaucoma.The Department does not hold information on the absolute numbers of people living with glaucoma at any one time in England, and therefore no estimate has been made on the numbers of people who will have glaucoma in the next 10 years. Data is also not held centrally on the number of qualified ophthalmic consultants and doctors who are able to treat glaucoma in the NHS.

Whether his Department has considered introducing a national screening programme for glaucoma.

The UK National Screening Committee does not recommend screening for glaucoma because it is not clear if the tests which are available are accurate enough to be used in a screening programme. Regular sight tests are important in detecting glaucoma, which is why we recommend everyone having a sight test at least every two years. Free National Health Service sight tests are available for many, including children, those aged 60 years old and over, individuals on income-related benefits, and those diagnosed with, or considered at risk of, glaucoma.The Department does not hold information on the absolute numbers of people living with glaucoma at any one time in England, and therefore no estimate has been made on the numbers of people who will have glaucoma in the next 10 years. Data is also not held centrally on the number of qualified ophthalmic consultants and doctors who are able to treat glaucoma in the NHS.

What discussions he has had with the Chancellor of the Exchequer on the release of Adult Social Care Funding Data, following the Information Tribunal order to disclose it in October 2024.

My Rt. Hon. friend, the Secretary of State for Health and Social Care, has regular conversations with the Chancellor of the Exchequer about a variety of topics.To enable local authorities to deliver key services such as adult social care, the Government has made available up to £3.7 billion of additional funding for social care authorities in 2025/26, which includes an £880 million increase in the Social Care Grant. The Government has provided an increase to core local government spending power in 2025/26 of up to 6.8% in cash terms.

What steps his Department is taking to reduce the time taken for patients experiencing Parkinson's symptoms to receive a Parkinson’s disease diagnosis.

The National Institute for Health and Care Excellence’s (NICE) guidance on Parkinson’s disease in adults sets out the best practice for healthcare professionals in the care, treatment, and support of people with Parkinson’s. It aims to improve the recognition and management of Parkinson’s symptoms. The NICE’s guidance on Parkinson’s disease in adults is available at the following link:https://www.nice.org.uk/guidance/ng71NHS RightCare has also produced a Progressive Neurology Conditions Toolkit. The toolkit sets out the key priorities for increasing knowledge of the signs and symptoms of Parkinson’s and makes suggestions regarding new service models which can be implemented in primary care to speed up referrals to specialists and ensure a timely diagnosis. Additionally, the Getting It Right First Time Programme for Neurology has published a National Speciality Report, which makes several recommendations in relation to reducing waiting for neurology services. NHS England has also established a Neurology Transformation Programme, a multi-year, clinically led programme which has developed a new model of integrated care for neurology services, to support integrated care boards to deliver the right service, at the right time for all neurology patients, including those with Parkinson’s.Data on how regularly an average patient with Parkinson’s disease sees a neurologist is not held centrally. NICE guidance recommends that people with Parkinson's should be seen at regular intervals of six to 12 months. While NICE guidance is not mandatory, the Government expects the healthcare system and commissioners to take the guidelines fully into account when designing services for their local population, and to work towards their implementation over time.Data on the average time taken for patients with Parkinson’s disease to see a neurologist is not held centrally. The latest data for referral to treatment waiting times in England, from February 2025, shows there were under 230,000 pathways waiting for a neurology appointment, 53.7% of which were waiting within 18 weeks.The NHS Constitution sets out that patients should start consultant-led treatment within a maximum of 18 weeks from referral for non-urgent conditions. On 6 January 2025, NHS England published the new Elective Reform Plan, which sets out a whole system approach to hitting the 18-week referral to treatment target by the end of this Parliament. We have achieved our pledge to deliver two million extra elective appointments. These additional appointments have taken place across a number of specialities, including neurology. We have made the commitment that 92% of patients will wait no longer than 18 weeks from referral to consultant-led treatment, in line with the NHS constitutional standard, by March 2029.

If he will make an estimate of the how regularly an average patient with Parkinson’s disease saw a neurologist in the latest period for which data was available.

The National Institute for Health and Care Excellence’s (NICE) guidance on Parkinson’s disease in adults sets out the best practice for healthcare professionals in the care, treatment, and support of people with Parkinson’s. It aims to improve the recognition and management of Parkinson’s symptoms. The NICE’s guidance on Parkinson’s disease in adults is available at the following link:https://www.nice.org.uk/guidance/ng71NHS RightCare has also produced a Progressive Neurology Conditions Toolkit. The toolkit sets out the key priorities for increasing knowledge of the signs and symptoms of Parkinson’s and makes suggestions regarding new service models which can be implemented in primary care to speed up referrals to specialists and ensure a timely diagnosis. Additionally, the Getting It Right First Time Programme for Neurology has published a National Speciality Report, which makes several recommendations in relation to reducing waiting for neurology services. NHS England has also established a Neurology Transformation Programme, a multi-year, clinically led programme which has developed a new model of integrated care for neurology services, to support integrated care boards to deliver the right service, at the right time for all neurology patients, including those with Parkinson’s.Data on how regularly an average patient with Parkinson’s disease sees a neurologist is not held centrally. NICE guidance recommends that people with Parkinson's should be seen at regular intervals of six to 12 months. While NICE guidance is not mandatory, the Government expects the healthcare system and commissioners to take the guidelines fully into account when designing services for their local population, and to work towards their implementation over time.Data on the average time taken for patients with Parkinson’s disease to see a neurologist is not held centrally. The latest data for referral to treatment waiting times in England, from February 2025, shows there were under 230,000 pathways waiting for a neurology appointment, 53.7% of which were waiting within 18 weeks.The NHS Constitution sets out that patients should start consultant-led treatment within a maximum of 18 weeks from referral for non-urgent conditions. On 6 January 2025, NHS England published the new Elective Reform Plan, which sets out a whole system approach to hitting the 18-week referral to treatment target by the end of this Parliament. We have achieved our pledge to deliver two million extra elective appointments. These additional appointments have taken place across a number of specialities, including neurology. We have made the commitment that 92% of patients will wait no longer than 18 weeks from referral to consultant-led treatment, in line with the NHS constitutional standard, by March 2029.

What recent estimate his Department has made of the average time taken for patients with Parkinson’s disease who are experiencing new symptoms to see a neurologist.

The National Institute for Health and Care Excellence’s (NICE) guidance on Parkinson’s disease in adults sets out the best practice for healthcare professionals in the care, treatment, and support of people with Parkinson’s. It aims to improve the recognition and management of Parkinson’s symptoms. The NICE’s guidance on Parkinson’s disease in adults is available at the following link:https://www.nice.org.uk/guidance/ng71NHS RightCare has also produced a Progressive Neurology Conditions Toolkit. The toolkit sets out the key priorities for increasing knowledge of the signs and symptoms of Parkinson’s and makes suggestions regarding new service models which can be implemented in primary care to speed up referrals to specialists and ensure a timely diagnosis. Additionally, the Getting It Right First Time Programme for Neurology has published a National Speciality Report, which makes several recommendations in relation to reducing waiting for neurology services. NHS England has also established a Neurology Transformation Programme, a multi-year, clinically led programme which has developed a new model of integrated care for neurology services, to support integrated care boards to deliver the right service, at the right time for all neurology patients, including those with Parkinson’s.Data on how regularly an average patient with Parkinson’s disease sees a neurologist is not held centrally. NICE guidance recommends that people with Parkinson's should be seen at regular intervals of six to 12 months. While NICE guidance is not mandatory, the Government expects the healthcare system and commissioners to take the guidelines fully into account when designing services for their local population, and to work towards their implementation over time.Data on the average time taken for patients with Parkinson’s disease to see a neurologist is not held centrally. The latest data for referral to treatment waiting times in England, from February 2025, shows there were under 230,000 pathways waiting for a neurology appointment, 53.7% of which were waiting within 18 weeks.The NHS Constitution sets out that patients should start consultant-led treatment within a maximum of 18 weeks from referral for non-urgent conditions. On 6 January 2025, NHS England published the new Elective Reform Plan, which sets out a whole system approach to hitting the 18-week referral to treatment target by the end of this Parliament. We have achieved our pledge to deliver two million extra elective appointments. These additional appointments have taken place across a number of specialities, including neurology. We have made the commitment that 92% of patients will wait no longer than 18 weeks from referral to consultant-led treatment, in line with the NHS constitutional standard, by March 2029.

What steps his Department is taking to ensure that people who need joint replacement surgery are able to access treatment in all regions.

The Government is committed to putting patients first, including those waiting for joint replacement surgery.We understand the impact long waits can have on patients’ mental health, and we are committed to ensuring that people can access high quality mental health support when they need it. As part of this, we will recruit 8,500 mental health workers to ease pressure on busy mental health services. Separately, in the Government’s Plan for Change we have committed to return to the 18-week Referral to Treatment standard, which has not been met for almost a decade.We will ensure that patients are not only seen on time but also have the best possible experience of care. Our Elective Reform Plan, published on 6 January 2025, has committed us to working with patients and their carers to co-develop minimum standards for their experience of care.Dedicated and protected surgical hubs are helping to reduce elective surgery wait times by focusing on high volume low complexity surgeries, such as joint replacement surgery. As of March 2025, there are 114 elective surgical hubs that are operational across England.The Elective Reform Plan has committed to providing quicker access for patients to common surgical hub procedures by opening 17 new and expanded surgical hubs by June 2025 and ramping up the number of hubs over the next three years, so even more operations can be carried out near where patients live.

Whether his Department plans to publish an implementation plan alongside the policy paper entitled Reforming elective care for patients, published on 6 January 2025.

There are currently no plans to publish an implementation plan alongside the Elective Reform Plan.Our Elective Reform Plan sets out the productivity and reform efforts needed to return to the 18-week constitutional standard by the end of this Parliament, and outlines how these will be implemented by National Health Service systems, including a series of milestones for delivery. We have hit our pledge to deliver two million extra elective appointments early, and have now exceeded that pledge by delivering over three million more appointments.In addition, the Planning Guidance for 2025/26 has since been published and confirmed the interim targets for 2025/26, including a target that 65% of patients wait for 18 weeks or less by March 2026, up from 58.9% in January 2025, with every trust expected to deliver a minimum 5% improvement on current performance over that period.

How many and what proportion of the new surgical hubs will be focused solely on orthopaedic procedures.

There are no plans for any of the new hubs to focus solely on orthopaedic procedures, but five of the new surgical hubs will focus on orthopaedics procedures in addition to other specialties.The Elective Reform Plan committed to providing quicker access for patients to common surgical procedures by opening 14 new and three expanded surgical hubs by June 2025, and ramping up the number of hubs over the next three years, so more operations can be carried out. They focus on driving improvements in six high volume specialties: ophthalmology; general surgery; trauma and orthopaedics, which includes spinal surgery; gynaecology; ear, nose and throat; and urology.

What steps his Department is taking to provide mental health support for people waiting for joint replacement surgery.

The Government is committed to putting patients first, including those waiting for joint replacement surgery.We understand the impact long waits can have on patients’ mental health, and we are committed to ensuring that people can access high quality mental health support when they need it. As part of this, we will recruit 8,500 mental health workers to ease pressure on busy mental health services. Separately, in the Government’s Plan for Change we have committed to return to the 18-week Referral to Treatment standard, which has not been met for almost a decade.We will ensure that patients are not only seen on time but also have the best possible experience of care. Our Elective Reform Plan, published on 6 January 2025, has committed us to working with patients and their carers to co-develop minimum standards for their experience of care.Dedicated and protected surgical hubs are helping to reduce elective surgery wait times by focusing on high volume low complexity surgeries, such as joint replacement surgery. As of March 2025, there are 114 elective surgical hubs that are operational across England.The Elective Reform Plan has committed to providing quicker access for patients to common surgical hub procedures by opening 17 new and expanded surgical hubs by June 2025 and ramping up the number of hubs over the next three years, so even more operations can be carried out near where patients live.

What steps his Department is taking to ensure that all relevant medical health professionals are aware of the different manifestations of Parkinson’s disease in (a) women and (b) men.

Guidance produced by the National Institute for Health and Care Excellence on Parkinson’s disease in adults does not make any reference to differences in Parkinson’s symptoms between women and men.We do know that the prevalence of Parkinson’s disease is higher in men than in women, as prevalence rates for men aged between 50 and 89 years old are more than 1.5 times higher than rates for women in the same age group. This equates to 22 in every 10,000 women and 32 in every 10,000 men diagnosed with Parkinson's disease.NHS England is updating the Neurosciences specialised neurology (adults) service specification, which includes Parkinson’s. The revised service specification also includes an annex which articulates minimum service requirements for both specialised and non-specialised neurology services, including movement disorder services. We are expecting the revised specification and standards to be published later in 2025.NHS England will publish an Equality and Health Inequalities Impact Assessment alongside the specification. This will summarise the different incidence and impacts of neurological disease on protected characteristic groups, drawing on published evidence as appropriate.

How many of the new surgical hubs will be focused solely on orthopaedic procedures.

The Elective Reform Plan has committed to providing quicker access for patients to common surgical hub procedures by opening 17 new and expanded surgical hubs by June 2025 and ramping up the number of hubs over the next three years, so more operations can be carried out.In line with direction set by the Getting it Right First Time High Volume Low Complexity programme, surgical hubs focus on driving improvement in six high volume specialties: ophthalmology; general surgery; trauma and orthopaedics, which includes spinal surgery; gynaecology; ear, nose and throat; and urology. There are no plans for any of the new hubs to solely focus on orthopaedic procedures.

What steps he is taking to ensure people who need joint replacement surgery are able to access treatment where they live.

The Government is committed to putting patients first, including those waiting for joint replacement surgery. Too many people have been left in limbo, with their personal and professional lives on hold waiting for National Health Service treatment. We understand the impact that long waits can have on patients’ mental health, which is why we have committed, in the Government’s Plan for Change, to return to the 18-week Referral to Treatment standard, which has not been met for almost a decade.We will ensure that patients are not only seen on time but also have the best possible experience of care. Our Elective Reform Plan, published on 6 January 2025, has committed us to working with patients and their carers to co-develop minimum standards for their experience of care.Dedicated and protected surgical hubs are helping to reduce elective surgery wait times by focusing on high volume low complexity surgeries, such as joint replacement surgery. As of March 2025, there are 114 elective surgical hubs that are operational across England.The Elective Reform Plan has committed to providing quicker access for patients to common surgical hub procedures by opening 17 new and expanded surgical hubs by June 2025, and by ramping up the number of hubs over the next three years, so even more operations can be carried out near where patients live.

Whether he is taking steps to provide mental health support for people waiting for joint replacement surgery.

The Government is committed to putting patients first, including those waiting for joint replacement surgery. Too many people have been left in limbo, with their personal and professional lives on hold waiting for National Health Service treatment. We understand the impact that long waits can have on patients’ mental health, which is why we have committed, in the Government’s Plan for Change, to return to the 18-week Referral to Treatment standard, which has not been met for almost a decade.We will ensure that patients are not only seen on time but also have the best possible experience of care. Our Elective Reform Plan, published on 6 January 2025, has committed us to working with patients and their carers to co-develop minimum standards for their experience of care.Dedicated and protected surgical hubs are helping to reduce elective surgery wait times by focusing on high volume low complexity surgeries, such as joint replacement surgery. As of March 2025, there are 114 elective surgical hubs that are operational across England.The Elective Reform Plan has committed to providing quicker access for patients to common surgical hub procedures by opening 17 new and expanded surgical hubs by June 2025, and by ramping up the number of hubs over the next three years, so even more operations can be carried out near where patients live.

Whether his Department plans to publish an implementation plan alongside the Elective Reform Plan.

There are currently no plans to publish an implementation plan alongside the Elective Reform Plan.Our Elective Reform Plan sets out the productivity and reform efforts needed to return to the 18-week constitutional standard by the end of this Parliament, and outlines how these will be implemented by National Health Service systems, including a series of milestones for delivery. We have already achieved our pledge to deliver two million extra elective appointments, as a first step to delivering on this commitment.In addition, the Planning Guidance for 2025/26 has since been published and confirmed the interim targets for 2025/26, including a target that 65% of patients wait for 18 weeks or less by March 2026, up from 58.9% as of January 2025, with every trust expected to deliver a minimum 5% improvement on current performance over that period.

What steps his Department is taking to ensure that healthcare settings provide (i) timely, (ii) clear, (iii) accurate and (iv) impartial information on the nutritional sufficiency of infant formula products and (b) implement standardised infant formula labelling on products.

Infant feeding is critical to a baby’s healthy growth and development. The Government is committed to giving every child the best start in life and that includes helping families to access support to feed their baby.Whilst breastfeeding has significant health benefits, we recognise that for those families that cannot or choose not to breastfeed, it is vital that they have access to infant formula that is affordable and high quality. Infant formula regulations ensure that all infant formula is suitable for meeting the nutritional needs of babies, regardless of the price or brand.The Government welcomes the Competition and Markets Authority’s market study report on infant formula and follow-on formula. The report included recommendations related to clear, accurate and impartial information on the nutritional sufficiency of all infant formula products on product labelling and in retail settings as well as a recommendation related to displaying all brands of infant formula together and separate from other formula milks. We will carefully consider its findings and recommendations and respond in due course.

What steps his Department is taking to ensure that retailers (a) provide (i) clear, (ii) accurate and (iii) impartial information on the nutritional sufficiency of infant formula products in (A) retail outlets and (B) online shopping channels and (b) display brands of infant formula together on retail shelves.

Infant feeding is critical to a baby’s healthy growth and development. The Government is committed to giving every child the best start in life and that includes helping families to access support to feed their baby.Whilst breastfeeding has significant health benefits, we recognise that for those families that cannot or choose not to breastfeed, it is vital that they have access to infant formula that is affordable and high quality. Infant formula regulations ensure that all infant formula is suitable for meeting the nutritional needs of babies, regardless of the price or brand.The Government welcomes the Competition and Markets Authority’s market study report on infant formula and follow-on formula. The report included recommendations related to clear, accurate and impartial information on the nutritional sufficiency of all infant formula products on product labelling and in retail settings as well as a recommendation related to displaying all brands of infant formula together and separate from other formula milks. We will carefully consider its findings and recommendations and respond in due course.

If he will publish funding by the Better Care Fund to support unpaid carers for (a) 2023 and (b) 2024, by region.

I refer the hon. Member to the answer I gave on 3 March 2025 to Question 33291.

If he will take steps to ensure that the results of the GBS3 trial are acted upon (a) quickly and (b) effectively.

The UK National Screening Committee (UK NSC) stands ready to receive the results of the GBS3 trial. The UK NSC Secretariat is in close and regular contact with the researchers. The committee will consider the evidence from the trial, once the report is available.